Skip to main content
logo
Concord Biotech Limited (NSE:CONCORDBIO)
India flag India · Delayed Price · Currency is INR
1,640.00
+1.20 (0.07%)
Sep 12, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019
Active Pharmaceutical Ingredients
9.40B
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients Growth
13.53%
Log In
Log In
Log In
Log In
Upgrade
Formulations
2.60B
Log In
Log In
Log In
Log In
Upgrade
Formulations Growth
37.63%
Log In
Log In
Log In
Log In
Upgrade
Bulk Drug
-
Log In
Log In
Log In
Log In
Upgrade
Bulk Drug Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019
India
6.62B
Log In
Log In
Log In
Log In
Upgrade
India Growth
23.89%
Log In
Log In
Log In
Log In
Upgrade
United States
1.38B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
27.77%
Log In
Log In
Log In
Log In
Upgrade
Other
4.00B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
6.81%
Log In
Log In
Log In
Log In
Upgrade